Yazar Veysi, Binici Orhan, Karahan Mahmut A, Bilsel Mehmet B, Pehlivan Veli F
Anesthesiology and Reanimation, Mehmet Akif Inan Training and Research Hospital, Şanlıurfa, TUR.
Anesthesiology and Critical Care, Harran University, Şanlıurfa, TUR.
Cureus. 2024 Jun 3;16(6):e61578. doi: 10.7759/cureus.61578. eCollection 2024 Jun.
Introduction In this study, we aimed to measure the change in total antioxidant status (TAS), total oxidant stress (TOS), oxidative stress index (OSI), and nuclear factor erythroid 2 (Nrf-2) levels during the treatment period in patients who restored spontaneous circulation return after cardiac arrest with targeted temperature management (TTM) therapy in our hospital. Methods The study included 36 patients who were hospitalized in the anesthesia intensive care unit and coronary intensive care unit of our hospital and were treated with TTM therapy after cardiac arrest. TAS, TOS, OSI, and Nrf-2 levels were measured at 0 (beginning), 12, 24, and 48 (end) hours of TTM therapy. Results The mean age of the patients participating in the study was 54.25±17.10. TAS and TOS levels decreased gradually during TTM therapy, but statistically significant decrease was observed at the end of the hour. When Nrf-2 and OSI levels were evaluated, it was found that no statistically significant difference was observed during the TTM therapy. Conclusion In our study, the oxidant-antioxidant balance was preserved in patients who received TTM therapy after cardiac arrest. We predict TTM therapy is effective on oxidative stress after cardiac arrest and should be applied for at least 48 hours.
引言 在本研究中,我们旨在测量我院接受目标温度管理(TTM)治疗的心脏骤停后恢复自主循环的患者在治疗期间总抗氧化状态(TAS)、总氧化应激(TOS)、氧化应激指数(OSI)和核因子红细胞2(Nrf-2)水平的变化。方法 本研究纳入了36例在我院麻醉重症监护病房和冠心病重症监护病房住院、心脏骤停后接受TTM治疗的患者。在TTM治疗的0(开始)、12、24和48(结束)小时测量TAS、TOS、OSI和Nrf-2水平。结果 参与研究的患者平均年龄为54.25±17.10。在TTM治疗期间,TAS和TOS水平逐渐下降,但在48小时结束时观察到有统计学意义的下降。评估Nrf-2和OSI水平时发现,在TTM治疗期间未观察到统计学意义上的差异。结论 在我们的研究中,心脏骤停后接受TTM治疗的患者氧化-抗氧化平衡得以维持。我们预测TTM治疗对心脏骤停后的氧化应激有效,应至少应用48小时。